4.7 Review

mTOR: from growth signal integration to cancer, diabetes and ageing

期刊

NATURE REVIEWS MOLECULAR CELL BIOLOGY
卷 12, 期 1, 页码 21-35

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nrm3025

关键词

-

资金

  1. US National Institutes of Health
  2. Howard Hughes Medical Institute
  3. Whitehead Institute for Biomedical Research
  4. Jane Coffin Childs Memorial Fund
  5. Human Frontier Science Program
  6. NATIONAL CANCER INSTITUTE [R01CA129105, R01CA103866] Funding Source: NIH RePORTER
  7. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389, R37AI047389] Funding Source: NIH RePORTER

向作者/读者索取更多资源

In all eukaryotes, the target of rapamycin (TOR) signalling pathway couples energy and nutrient abundance to the execution of cell growth and division, owing to the ability of TOR protein kinase to simultaneously sense energy, nutrients and stress and, in metazoans, growth factors. Mammalian TOR complex 1 (mTORC1) and mTORC2 exert their actions by regulating other important kinases, such as S6 kinase (S6K) and Akt. In the past few years, a significant advance in our understanding of the regulation and functions of mTOR has revealed the crucial involvement of this signalling pathway in the onset and progression of diabetes, cancer and ageing.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据